SCHEMBL979074

SCHEMBL979074

COc1cccc2cc(C(=O)Nc3cccc(-c4ccccc4C#N)c3)c(=O)oc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.61
MAPT P10636 3/20 0.56
TP53 P04637 2/20 0.56
HSD17B10 Q99714 1/20 0.56
RAB9A P51151 3/20 0.54
ALDH1A1 P00352 2/20 0.52
GLA P06280 1/20 0.52
NPC1 O15118 3/20 0.52
MAOB P27338 2/20 0.52
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA3 P07451 1/20 0.51
CA4 P22748 1/20 0.51
CA6 P23280 1/20 0.51
CA5A P35218 1/20 0.51
CA7 P43166 1/20 0.51
CA9 Q16790 1/20 0.51
CA14 Q9ULX7 1/20 0.51
CA5B Q9Y2D0 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL979711 0.89 CASP3 (0.48) CASP3MAPTTP53HSD17B10RAB9A
SCHEMBL980797 0.88 AKR1C3 (0.50) CASP3TP53RAB9AALDH1A1GLA
SCHEMBL979434 0.86 CASP3 (0.57) CASP3MAPTTP53HSD17B10RAB9A
SCHEMBL980813 0.86 CASP3 (0.57) CASP3MAPTTP53HSD17B10RAB9A
SCHEMBL978085 0.84 ALDH1A1 (0.62) CASP3MAPTTP53HSD17B10RAB9A
SCHEMBL982817 0.84 CASP3 (0.61) CASP3MAPTTP53HSD17B10RAB9A
SCHEMBL980243 0.82 CASP3 (0.61) CASP3MAPTTP53HSD17B10RAB9A
SCHEMBL980096 0.82 CASP3 (0.61) CASP3MAPTTP53HSD17B10RAB9A
SCHEMBL981812 0.82 MAPT (0.78) CASP3MAPTTP53HSD17B10RAB9A
SCHEMBL980338 0.82 CASP3 (0.61) CASP3MAPTTP53HSD17B10RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021522-A1 ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021522-A1 ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 CASP7, CASP3, CASP6 CASP3 2/4885MAPT 3013/4885TP53 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.